SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b):
SEC Accession No. 0001193125-13-250177
Filing Date
2013-06-06
Accepted
2013-06-06 16:55:12
Documents
8
Period of Report
2013-05-31
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K12B d548510d8k12b.htm 8-K12B 48137
2 EX-2.1 d548510dex21.htm EX-2.1 26688
3 EX-3.1 d548510dex31.htm EX-3.1 19913
4 EX-3.2 d548510dex32.htm EX-3.2 167220
5 EX-4.1 d548510dex41.htm EX-4.1 21798
6 EX-10.1 d548510dex101.htm EX-10.1 105584
7 EX-10.2 d548510dex102.htm EX-10.2 58006
8 GRAPHIC g548510img01.jpg GRAPHIC 18953
  Complete submission text file 0001193125-13-250177.txt   475397
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K12B | Act: 34 | File No.: 001-14895 | Film No.: 13897897
SIC: 2834 Pharmaceutical Preparations